Application of the screening method for estimating COVID-19 vaccine effectiveness using routine surveillance data: Germany's experience during the COVID-19 pandemic, July 2021 to March 2023.

Journal Information

Full Title: Euro Surveill

Abbreviation: Euro Surveill

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"however aggregated data on covid-19 vaccinations cases and hospitalisations in germany are publicly available for download from rki's github repository: https://github com/robert-koch-institut ."

Evidence found in paper:

"however aggregated data on covid-19 vaccinations cases and hospitalisations in germany are publicly available for download from rki's github repository: https://github com/robert-koch-institut ."

Evidence found in paper:

"Conflict of interest: None declared."

Evidence found in paper:

"Funding statement No specific funding was received for this study from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025